Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1929 3
1930 1
1931 1
1951 2
1953 3
1954 3
1955 1
1956 1
1957 1
1958 2
1959 5
1960 3
1961 1
1962 2
1963 2
1964 1
1965 1
1966 2
1968 2
1970 1
1971 1
1972 2
1973 2
1974 2
1975 2
1976 1
1979 2
1980 2
1985 1
1987 2
1990 2
1991 1
1992 3
1994 4
1995 2
1996 6
1997 8
1998 5
1999 10
2000 8
2001 7
2002 14
2003 18
2004 18
2005 18
2006 19
2007 22
2008 28
2009 19
2010 20
2011 32
2012 34
2013 41
2014 59
2015 67
2016 33
2017 37
2018 32
2019 30
2020 44
2021 46
2022 44
2023 47
2024 26

Text availability

Article attribute

Article type

Publication date

Search Results

785 results

Results by year

Filters applied: . Clear all
Page 1
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial.
Wang-Gillam A, Li CP, Bodoky G, Dean A, Shan YS, Jameson G, Macarulla T, Lee KH, Cunningham D, Blanc JF, Hubner RA, Chiu CF, Schwartsmann G, Siveke JT, Braiteh F, Moyo V, Belanger B, Dhindsa N, Bayever E, Von Hoff DD, Chen LT; NAPOLI-1 Study Group. Wang-Gillam A, et al. Among authors: li cp. Lancet. 2016 Feb 6;387(10018):545-557. doi: 10.1016/S0140-6736(15)00986-1. Epub 2015 Nov 29. Lancet. 2016. PMID: 26615328 Clinical Trial.
Chimeric CRISPR-CasX enzymes and guide RNAs for improved genome editing activity.
Tsuchida CA, Zhang S, Doost MS, Zhao Y, Wang J, O'Brien E, Fang H, Li CP, Li D, Hai ZY, Chuck J, Brötzmann J, Vartoumian A, Burstein D, Chen XW, Nogales E, Doudna JA, Liu JG. Tsuchida CA, et al. Among authors: li cp. Mol Cell. 2022 Mar 17;82(6):1199-1209.e6. doi: 10.1016/j.molcel.2022.02.002. Epub 2022 Feb 25. Mol Cell. 2022. PMID: 35219382 Free PMC article.
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial.
Tempero MA, Pelzer U, O'Reilly EM, Winter J, Oh DY, Li CP, Tortora G, Chang HM, Lopez CD, Bekaii-Saab T, Ko AH, Santoro A, Park JO, Noel MS, Frassineti GL, Shan YS, Dean A, Riess H, Van Cutsem E, Berlin J, Philip P, Moore M, Goldstein D, Tabernero J, Li M, Ferrara S, Le Bruchec Y, Zhang G, Lu B, Biankin AV, Reni M; APACT Investigators. Tempero MA, et al. Among authors: li cp. J Clin Oncol. 2023 Apr 10;41(11):2007-2019. doi: 10.1200/JCO.22.01134. Epub 2022 Dec 15. J Clin Oncol. 2023. PMID: 36521097 Free PMC article. Clinical Trial.
Narrative review of ferroptosis in obesity.
He LP, Zhou ZX, Li CP. He LP, et al. Among authors: li cp. J Cell Mol Med. 2023 Apr;27(7):920-926. doi: 10.1111/jcmm.17701. Epub 2023 Mar 5. J Cell Mol Med. 2023. PMID: 36871273 Free PMC article. Review.
785 results